Cancer/Tumor Profiling and Pathways and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Cancer/Tumor Profiling and Pathways Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cancer/Tumor Profiling and Pathways Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cancer/Tumor Profiling and Pathways Overall Market Size
2.1 Global Cancer/Tumor Profiling and Pathways Market Size: 2021 VS 2028
2.2 Global Cancer/Tumor Profiling and Pathways Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cancer/Tumor Profiling and Pathways Players in Global Market
3.2 Top Global Cancer/Tumor Profiling and Pathways Companies Ranked by Revenue
3.3 Global Cancer/Tumor Profiling and Pathways Revenue by Companies
3.4 Top 3 and Top 5 Cancer/Tumor Profiling and Pathways Companies in Global Market, by Revenue in 2021
3.5 Global Companies Cancer/Tumor Profiling and Pathways Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cancer/Tumor Profiling and Pathways Players in Global Market
3.6.1 List of Global Tier 1 Cancer/Tumor Profiling and Pathways Companies
3.6.2 List of Global Tier 2 and Tier 3 Cancer/Tumor Profiling and Pathways Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Cancer/Tumor Profiling and Pathways Market Size Markets, 2021 & 2028
4.1.2 Immunoassays
4.1.3 Next Generation Sequencing (NGS)
4.1.4 Polymerase Chain Reaction (PCR)
4.1.5 In-Situ Hybridization (ISH)
4.1.6 Microarrays
4.1.7 Mass Spectrometry
4.1.8 Others
4.2 By Type - Global Cancer/Tumor Profiling and Pathways Revenue & Forecasts
4.2.1 By Type - Global Cancer/Tumor Profiling and Pathways Revenue, 2017-2022
4.2.2 By Type - Global Cancer/Tumor Profiling and Pathways Revenue, 2023-2028
4.2.3 By Type - Global Cancer/Tumor Profiling and Pathways Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cancer/Tumor Profiling and Pathways Market Size, 2021 & 2028
5.1.2 Research
5.1.3 Clinical
5.2 By Application - Global Cancer/Tumor Profiling and Pathways Revenue & Forecasts
5.2.1 By Application - Global Cancer/Tumor Profiling and Pathways Revenue, 2017-2022
5.2.2 By Application - Global Cancer/Tumor Profiling and Pathways Revenue, 2023-2028
5.2.3 By Application - Global Cancer/Tumor Profiling and Pathways Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Cancer/Tumor Profiling and Pathways Market Size, 2021 & 2028
6.2 By Region - Global Cancer/Tumor Profiling and Pathways Revenue & Forecasts
6.2.1 By Region - Global Cancer/Tumor Profiling and Pathways Revenue, 2017-2022
6.2.2 By Region - Global Cancer/Tumor Profiling and Pathways Revenue, 2023-2028
6.2.3 By Region - Global Cancer/Tumor Profiling and Pathways Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Cancer/Tumor Profiling and Pathways Revenue, 2017-2028
6.3.2 US Cancer/Tumor Profiling and Pathways Market Size, 2017-2028
6.3.3 Canada Cancer/Tumor Profiling and Pathways Market Size, 2017-2028
6.3.4 Mexico Cancer/Tumor Profiling and Pathways Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Cancer/Tumor Profiling and Pathways Revenue, 2017-2028
6.4.2 Germany Cancer/Tumor Profiling and Pathways Market Size, 2017-2028
6.4.3 France Cancer/Tumor Profiling and Pathways Market Size, 2017-2028
6.4.4 U.K. Cancer/Tumor Profiling and Pathways Market Size, 2017-2028
6.4.5 Italy Cancer/Tumor Profiling and Pathways Market Size, 2017-2028
6.4.6 Russia Cancer/Tumor Profiling and Pathways Market Size, 2017-2028
6.4.7 Nordic Countries Cancer/Tumor Profiling and Pathways Market Size, 2017-2028
6.4.8 Benelux Cancer/Tumor Profiling and Pathways Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Cancer/Tumor Profiling and Pathways Revenue, 2017-2028
6.5.2 China Cancer/Tumor Profiling and Pathways Market Size, 2017-2028
6.5.3 Japan Cancer/Tumor Profiling and Pathways Market Size, 2017-2028
6.5.4 South Korea Cancer/Tumor Profiling and Pathways Market Size, 2017-2028
6.5.5 Southeast Asia Cancer/Tumor Profiling and Pathways Market Size, 2017-2028
6.5.6 India Cancer/Tumor Profiling and Pathways Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Cancer/Tumor Profiling and Pathways Revenue, 2017-2028
6.6.2 Brazil Cancer/Tumor Profiling and Pathways Market Size, 2017-2028
6.6.3 Argentina Cancer/Tumor Profiling and Pathways Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cancer/Tumor Profiling and Pathways Revenue, 2017-2028
6.7.2 Turkey Cancer/Tumor Profiling and Pathways Market Size, 2017-2028
6.7.3 Israel Cancer/Tumor Profiling and Pathways Market Size, 2017-2028
6.7.4 Saudi Arabia Cancer/Tumor Profiling and Pathways Market Size, 2017-2028
6.7.5 UAE Cancer/Tumor Profiling and Pathways Market Size, 2017-2028
7 Players Profiles
7.1 Illumina, Inc. (US)
7.1.1 Illumina, Inc. (US) Corporate Summary
7.1.2 Illumina, Inc. (US) Business Overview
7.1.3 Illumina, Inc. (US) Cancer/Tumor Profiling and Pathways Major Product Offerings
7.1.4 Illumina, Inc. (US) Cancer/Tumor Profiling and Pathways Revenue in Global Market (2017-2022)
7.1.5 Illumina, Inc. (US) Key News
7.2 QIAGEN N.V. (Germany)
7.2.1 QIAGEN N.V. (Germany) Corporate Summary
7.2.2 QIAGEN N.V. (Germany) Business Overview
7.2.3 QIAGEN N.V. (Germany) Cancer/Tumor Profiling and Pathways Major Product Offerings
7.2.4 QIAGEN N.V. (Germany) Cancer/Tumor Profiling and Pathways Revenue in Global Market (2017-2022)
7.2.5 QIAGEN N.V. (Germany) Key News
7.3 NeoGenomics Laboratories, Inc. (US)
7.3.1 NeoGenomics Laboratories, Inc. (US) Corporate Summary
7.3.2 NeoGenomics Laboratories, Inc. (US) Business Overview
7.3.3 NeoGenomics Laboratories, Inc. (US) Cancer/Tumor Profiling and Pathways Major Product Offerings
7.3.4 NeoGenomics Laboratories, Inc. (US) Cancer/Tumor Profiling and Pathways Revenue in Global Market (2017-2022)
7.3.5 NeoGenomics Laboratories, Inc. (US) Key News
7.4 HTG Molecular Diagnostics, Inc. (US)
7.4.1 HTG Molecular Diagnostics, Inc. (US) Corporate Summary
7.4.2 HTG Molecular Diagnostics, Inc. (US) Business Overview
7.4.3 HTG Molecular Diagnostics, Inc. (US) Cancer/Tumor Profiling and Pathways Major Product Offerings
7.4.4 HTG Molecular Diagnostics, Inc. (US) Cancer/Tumor Profiling and Pathways Revenue in Global Market (2017-2022)
7.4.5 HTG Molecular Diagnostics, Inc. (US) Key News
7.5 Sysmex Corporation (Japan)
7.5.1 Sysmex Corporation (Japan) Corporate Summary
7.5.2 Sysmex Corporation (Japan) Business Overview
7.5.3 Sysmex Corporation (Japan) Cancer/Tumor Profiling and Pathways Major Product Offerings
7.5.4 Sysmex Corporation (Japan) Cancer/Tumor Profiling and Pathways Revenue in Global Market (2017-2022)
7.5.5 Sysmex Corporation (Japan) Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Cancer/Tumor Profiling and Pathways Market Opportunities & Trends in Global Market
Table 2. Cancer/Tumor Profiling and Pathways Market Drivers in Global Market
Table 3. Cancer/Tumor Profiling and Pathways Market Restraints in Global Market
Table 4. Key Players of Cancer/Tumor Profiling and Pathways in Global Market
Table 5. Top Cancer/Tumor Profiling and Pathways Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Cancer/Tumor Profiling and Pathways Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Cancer/Tumor Profiling and Pathways Revenue Share by Companies, 2017-2022
Table 8. Global Companies Cancer/Tumor Profiling and Pathways Product Type
Table 9. List of Global Tier 1 Cancer/Tumor Profiling and Pathways Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cancer/Tumor Profiling and Pathways Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Cancer/Tumor Profiling and Pathways Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Cancer/Tumor Profiling and Pathways Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Cancer/Tumor Profiling and Pathways Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Cancer/Tumor Profiling and Pathways Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Cancer/Tumor Profiling and Pathways Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Cancer/Tumor Profiling and Pathways Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Cancer/Tumor Profiling and Pathways Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Cancer/Tumor Profiling and Pathways Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Cancer/Tumor Profiling and Pathways Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Cancer/Tumor Profiling and Pathways Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Cancer/Tumor Profiling and Pathways Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Cancer/Tumor Profiling and Pathways Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Cancer/Tumor Profiling and Pathways Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Cancer/Tumor Profiling and Pathways Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Cancer/Tumor Profiling and Pathways Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Cancer/Tumor Profiling and Pathways Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Cancer/Tumor Profiling and Pathways Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Cancer/Tumor Profiling and Pathways Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Cancer/Tumor Profiling and Pathways Revenue, (US$, Mn), 2023-2028
Table 30. Illumina, Inc. (US) Corporate Summary
Table 31. Illumina, Inc. (US) Cancer/Tumor Profiling and Pathways Product Offerings
Table 32. Illumina, Inc. (US) Cancer/Tumor Profiling and Pathways Revenue (US$, Mn), (2017-2022)
Table 33. QIAGEN N.V. (Germany) Corporate Summary
Table 34. QIAGEN N.V. (Germany) Cancer/Tumor Profiling and Pathways Product Offerings
Table 35. QIAGEN N.V. (Germany) Cancer/Tumor Profiling and Pathways Revenue (US$, Mn), (2017-2022)
Table 36. NeoGenomics Laboratories, Inc. (US) Corporate Summary
Table 37. NeoGenomics Laboratories, Inc. (US) Cancer/Tumor Profiling and Pathways Product Offerings
Table 38. NeoGenomics Laboratories, Inc. (US) Cancer/Tumor Profiling and Pathways Revenue (US$, Mn), (2017-2022)
Table 39. HTG Molecular Diagnostics, Inc. (US) Corporate Summary
Table 40. HTG Molecular Diagnostics, Inc. (US) Cancer/Tumor Profiling and Pathways Product Offerings
Table 41. HTG Molecular Diagnostics, Inc. (US) Cancer/Tumor Profiling and Pathways Revenue (US$, Mn), (2017-2022)
Table 42. Sysmex Corporation (Japan) Corporate Summary
Table 43. Sysmex Corporation (Japan) Cancer/Tumor Profiling and Pathways Product Offerings
Table 44. Sysmex Corporation (Japan) Cancer/Tumor Profiling and Pathways Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Cancer/Tumor Profiling and Pathways Segment by Type in 2021
Figure 2. Cancer/Tumor Profiling and Pathways Segment by Application in 2021
Figure 3. Global Cancer/Tumor Profiling and Pathways Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Cancer/Tumor Profiling and Pathways Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Cancer/Tumor Profiling and Pathways Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cancer/Tumor Profiling and Pathways Revenue in 2021
Figure 8. By Type - Global Cancer/Tumor Profiling and Pathways Revenue Market Share, 2017-2028
Figure 9. By Application - Global Cancer/Tumor Profiling and Pathways Revenue Market Share, 2017-2028
Figure 10. By Region - Global Cancer/Tumor Profiling and Pathways Revenue Market Share, 2017-2028
Figure 11. By Country - North America Cancer/Tumor Profiling and Pathways Revenue Market Share, 2017-2028
Figure 12. US Cancer/Tumor Profiling and Pathways Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Cancer/Tumor Profiling and Pathways Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Cancer/Tumor Profiling and Pathways Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Cancer/Tumor Profiling and Pathways Revenue Market Share, 2017-2028
Figure 16. Germany Cancer/Tumor Profiling and Pathways Revenue, (US$, Mn), 2017-2028
Figure 17. France Cancer/Tumor Profiling and Pathways Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Cancer/Tumor Profiling and Pathways Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Cancer/Tumor Profiling and Pathways Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Cancer/Tumor Profiling and Pathways Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Cancer/Tumor Profiling and Pathways Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Cancer/Tumor Profiling and Pathways Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Cancer/Tumor Profiling and Pathways Revenue Market Share, 2017-2028
Figure 24. China Cancer/Tumor Profiling and Pathways Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Cancer/Tumor Profiling and Pathways Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Cancer/Tumor Profiling and Pathways Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Cancer/Tumor Profiling and Pathways Revenue, (US$, Mn), 2017-2028
Figure 28. India Cancer/Tumor Profiling and Pathways Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Cancer/Tumor Profiling and Pathways Revenue Market Share, 2017-2028
Figure 30. Brazil Cancer/Tumor Profiling and Pathways Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Cancer/Tumor Profiling and Pathways Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Cancer/Tumor Profiling and Pathways Revenue Market Share, 2017-2028
Figure 33. Turkey Cancer/Tumor Profiling and Pathways Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Cancer/Tumor Profiling and Pathways Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Cancer/Tumor Profiling and Pathways Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Cancer/Tumor Profiling and Pathways Revenue, (US$, Mn), 2017-2028
Figure 37. Illumina, Inc. (US) Cancer/Tumor Profiling and Pathways Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. QIAGEN N.V. (Germany) Cancer/Tumor Profiling and Pathways Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. NeoGenomics Laboratories, Inc. (US) Cancer/Tumor Profiling and Pathways Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. HTG Molecular Diagnostics, Inc. (US) Cancer/Tumor Profiling and Pathways Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Sysmex Corporation (Japan) Cancer/Tumor Profiling and Pathways Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
